- Active not recruitingPHASE3
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
This study looks at the long-term safety and effectiveness of a medicine called ofatumumab for people with relapsing MS. It also checks how well vaccines work in people taking this medicine, including those for flu, pneumonia, tetanus, and COVID-19.
For: Relapsing Multiple SclerosisUnited States · Argentina · Australia - Active not recruitingPHASE3
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis
This study looks at two new medicines, ofatumumab and siponimod, for children and teenagers aged 10-17 with multiple sclerosis (MS). It compares them to a medicine called fingolimod to see if they are safe and work well.
For: Multiple Sclerosis (MS)United States · Argentina · Australia - Recruiting
A Non-interventional Study Evaluating Clinical Utility and Implications on Improved Patient Management of Serum Neurofilament as a Prognostic Marker for Disease Activity in Patients With Relapsing Multiple Sclerosis
This study looks at how a blood test called serum neurofilament (sNfL) can help doctors manage multiple sclerosis (MS). It follows people with MS in Germany who are routinely tested and either continue their current treatment or switch to a new one called ofatumumab.
For: Multiple SclerosisGermany - Recruiting
A NIS Evaluating Various Injectable and Oral Treatments in Patients With Relapsing Multiple Sclerosis
This study looks at different approved medicines for Relapsing Multiple Sclerosis (RMS) in Germany. It observes patients already starting these treatments to see how they work in real-world settings over several years.
For: Relapsing Multiple SclerosisGermany